RecruitingNCT05907681
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
Sponsor
Samsung Medical Center
Enrollment
400 participants
Start Date
May 11, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.
Eligibility
Sex: FEMALEMin Age: 19 YearsMax Age: 100 Years
Inclusion Criteria4
- histologically confirmed breast cancer
- presence of distant metastasis
- radiation therapy using IMRT, SBRT, or proton therapy is done or planned
- Able and willing to comply with the study protocol
Exclusion Criteria1
- unable to adhere to the study protocol
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05907681
Related Trials
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892139 locations
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
NCT066493311 location
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations